VZV Pneumonia in Patients with Systemic Lupus Erythematosus.
- Author:
Hye Ryeon YUN
1
;
Won MOON
;
Ji Yong MOON
;
Ho Yong PARK
;
Joong Ho BAE
;
Won SOHN
;
Sang Cheol BAE
;
Hyunjoo PAI
Author Information
1. Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea. paihj@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Varicella-zoster virus pneumonia;
SLE;
Immunodeficiency
- MeSH:
Acyclovir;
Adult;
Chickenpox;
Herpes Zoster;
Herpesviridae;
Herpesvirus 3, Human;
Humans;
Lupus Erythematosus, Systemic*;
Pneumonia*
- From:
Infection and Chemotherapy
2005;37(3):180-184
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Varicella-zoster virus (VZV) is a member of the herpesviridae, which shares the characteristics of latent infection and reactivation. VZV causes two distinct clinical entities; varicella (chickenpox) and herpes zoster (shingles). Varicella pneumonia is the most common complication of adult varicella, especially in patients who are immunocompromised. We present two cases of VZV pneumonia occuring in patients with systemic lupus erythematosus (SLE) who were being treated with cytotoxic drugs and steroid. Both patients were treated with acyclovir and responses were good.
